Introduction
This report provides an in-depth analysis of the clinical nutrition industry within the US and EU, including sales forecasts from 2008 to 2013. It offers a detailed breakdown of the products, positions and market shares of the leading manufacturers of clinical nutrition products, as well as a discussion of other important players such as ingredient suppliers and service providers.
Scope of this research
- Analysis of why the clinical nutrition market is growing so quickly.
- Examination of which segment of the clinical nutrition market will experience the strongest growth.
- Discussion of what patient population will drive the greatest market growth.
- Overview of which diseases account for the greatest proportion of clinical nutrition patients.
Research and analysis highlights
Parenteral nutrition will demonstrate the strongest growth, at 11.3% per year, on average, followed by enteral nutrition with 7.4% annual growth and infant nutrition with 7.0%.
In the US, approximately 465,000 persons relied upon clinical nutrition in 2008. Over the next five years, this group will expand by 8.7% per year, with the greatest growth in the parenteral segment (11.3% annually) followed by enteral tube feeding (8.9% per year).
In the EU, more than 650,000 individuals utilized clinical nutrition in 2008. Through to 2013, the total number of European clinical nutrition patients will expand by 7.7% per year.
Key reasons to purchase this research
- Understand the latest trends in clinical nutrition patients and identify the products and ingredients associated with each term of treatment.
- Quantify future growth areas in the clinical nutrition market based on this report's analysis and forecasts of the market by region and segment.
- Identify the drivers and key issues that are shaping the clinical nutrition segment across the EU and the US.
- Benchmark your competitive position against others in the clinical nutrition market using this report's analysis of the performance of key players.